HIGHLIGHTS
- who: Feifei Li from the Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China have published the Article: Investigating the mechanism of Xian-ling-lian-xia-fang for inhibiting vasculogenic mimicry in triple negative breast cancer via blocking VEGF/MMPs pathway, in the Journal: (JOURNAL)
- what: The anti-TNBC mechanism of XLLXF was explored by combining network pharmacology and experimental verification.
- how: The results indicated that XLLXF may play an anti-TNBC role mainly through cancer-related pathways PI3K/Akt signaling pathways TNF signaling pathways HIF-1 signaling pathways MAPK signaling pathways . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.